Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bicalutamide With or Without Metformin in Overweight/Obese Prostate Cancer (BIMET-1)
NCT02614859Phase 2Completed
- Sponsor
- Fox Chase Cancer Center
- Start
- Dec 2015
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in prostate cancer (PCa), sponsored by Fox Chase Cancer Center. Started Dec 2015; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02614859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02614859.